This clinical trial is focused on studying the effects of a treatment called vosoritide in children with certain growth-related conditions. These conditions include Turner Syndrome, Short Stature Homeobox-Containing Gene Deficiency, and Noonan Syndrome. These are genetic conditions that can affect growth and development in children. The study will compare the effects of vosoritide with those of continued treatment with human growth hormone (hGH), which is a common treatment for these conditions.
The purpose of the study is to evaluate how different doses of vosoritide affect growth in children who have not responded adequately to hGH. The study will involve children who have been receiving hGH for at least a year. Participants will be randomly assigned to receive either vosoritide or continue with hGH. The study will last for several months, during which the growth of the children will be monitored and compared.
Throughout the study, researchers will observe changes in growth and monitor for any side effects. The study aims to provide insights into whether vosoritide can be an effective alternative or addition to hGH for improving growth in children with these specific conditions. The study will also track other health indicators to ensure the safety and effectiveness of the treatment. The results will help determine if vosoritide can be a beneficial treatment option for children with these growth challenges.



France
Germany
Italy
Spain